XML 64 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Our Divisions (COVID-19) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 25, 2021
Dec. 26, 2020
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact $ (32) $ 56
Prepaid Incentives Novel Coronavirus (COVID-19) Impact (23) 59
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact (1) 72
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 128 350
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 70 161
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 6 76
Charges Related to Novel Coronavirus (COVID-19) 148 774
Reserve for Product Returns Novel Coronavirus (COVID-19) Impact   20
Social Welfare Credit Novel Coronavirus (COVID-19) Impact   11
Frito Lay North America [Member]    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact (8) 17
Prepaid Incentives Novel Coronavirus (COVID-19) Impact 0 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 0 8
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 35 145
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 27 59
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 2 0
Charges Related to Novel Coronavirus (COVID-19) 56 229
Quaker Foods North America [Member]    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact (1) 2
Prepaid Incentives Novel Coronavirus (COVID-19) Impact 0 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 0 0
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 2 9
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 1 3
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 0 1
Charges Related to Novel Coronavirus (COVID-19) 2 15
PepsiCo Beverages North America [Member]    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact (19) 29
Prepaid Incentives Novel Coronavirus (COVID-19) Impact (21) 56
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 0 28
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 31 115
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 14 50
Charges Related to Novel Coronavirus (COVID-19) Impact - Other (16) 26
Charges Related to Novel Coronavirus (COVID-19) (11) 304
Africa, Middle East and South Asia [Member]    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact (1) 2
Prepaid Incentives Novel Coronavirus (COVID-19) Impact 0 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact (2) 3
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 1 9
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 3 7
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 6 12
Charges Related to Novel Coronavirus (COVID-19) 7 33
Asia Pacific, Australia and New Zealand, and China Region [Member]    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact 0 0
Prepaid Incentives Novel Coronavirus (COVID-19) Impact 0 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 0 3
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 2 (7)
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 2 2
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 5 5
Charges Related to Novel Coronavirus (COVID-19) 9 3
Latin America    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact 0 1
Prepaid Incentives Novel Coronavirus (COVID-19) Impact 0 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 1 19
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 44 56
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 15 18
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 4 8
Charges Related to Novel Coronavirus (COVID-19) 64 102
Europe    
Segment Reporting Information [Line Items]    
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact (3) 5
Prepaid Incentives Novel Coronavirus (COVID-19) Impact (2) 3
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact 0 11
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact 13 23
Employee Protection Costs Novel Coronavirus (COVID-19) Impact 8 22
Charges Related to Novel Coronavirus (COVID-19) Impact - Other 5 24
Charges Related to Novel Coronavirus (COVID-19) $ 21 $ 88